Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Acutus Medical Inc
Nieuws
Acutus Medical Inc
AFIB
NAS
: AFIB
| ISIN: US0051111096
30/04/2025
0,030 USD
(-28,57%)
(-28,57%)
30/04/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
14 april 2022 ·
AFIB Investors Have Opportunity to Lead Acutus Medical, Inc. Securities Fraud Lawsuit
· Persbericht
14 april 2022 ·
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
· Persbericht
14 april 2022 ·
MONDAY DEADLINE: Acutus Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
· Persbericht
7 april 2022 ·
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
· Persbericht
31 maart 2022 ·
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
· Persbericht
24 maart 2022 ·
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
· Persbericht
17 maart 2022 ·
AFIB UPCOMING DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Acutus Medical, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit
· Persbericht
17 maart 2022 ·
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
· Persbericht
15 maart 2022 ·
Investor Notice: Lawsuit for Investors who Lost over $50,000 in Acutus Medical, Inc shares announced by Shareholders Foundation
· Persbericht
14 maart 2022 ·
AFIB Investors Have Opportunity To Lead Acutus Medical, Inc. Securities Fraud Lawsuit
· Persbericht
10 maart 2022 ·
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
· Persbericht
5 maart 2022 ·
ACUTUS MEDICAL UPDATE: Berger Montague Investigates Securities Fraud Allegations Against Acutus Medical, Inc. (NASDAQ: AFIB); Lead Plaintiff Deadline is April 18, 2022
· Persbericht
3 maart 2022 ·
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors Of A Class Action Lawsuit And Upcoming Deadline
· Persbericht
24 februari 2022 ·
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
· Persbericht
22 februari 2022 ·
AFIB ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Acutus Medical, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit
· Persbericht
17 februari 2022 ·
AFIB Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Notifies Acutus Medical, Inc. Investors of Class Action and Encourages Investors to Contact the Firm
· Persbericht
17 februari 2022 ·
AFIB DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Acutus Medical, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
· Persbericht
27 juli 2021 ·
AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias
· Persbericht
18 maart 2021 ·
Acutus Medical Board Appoints John Sheridan as a New Director
· Persbericht
18 maart 2021 ·
Acutus Medical Reports Fourth Quarter and Full Year 2020 Financial Results
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe